Krebs Biochemicals & Industries (BOM:524518) Scaled Net Operating Assets : N/A (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Krebs Biochemicals & Industries's operating assets for the quarter that ended in Mar. 2024 was ₹1,750.2 Mil. Krebs Biochemicals & Industries's operating liabilities for the quarter that ended in Mar. 2024 was ₹1,039.6 Mil. Krebs Biochemicals & Industries's Total Assets for the quarter that ended in Dec. 2023 was ₹0.0 Mil. Therefore, Krebs Biochemicals & Industries's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was N/A.

Krebs Biochemicals & Industries Scaled Net Operating Assets Historical Data

The historical data trend for Krebs Biochemicals & Industries's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krebs Biochemicals & Industries Scaled Net Operating Assets Chart

Krebs Biochemicals & Industries Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.39

0.62

0.71

0.68

0.41

Krebs Biochemicals & Industries Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Krebs Biochemicals & Industries's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Krebs Biochemicals & Industries's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's Scaled Net Operating Assets falls into.

Krebs Biochemicals & Industries Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Krebs Biochemicals & Industries's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(1750.244	-	1039.619)	/	1749.817
=	0.41

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1781.747	-	31.503
=	1750.244

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2973.914	-	1835	-	99.295
=	1039.619

Krebs Biochemicals & Industries's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(1750.244	-	1039.619)	/	0
=	N/A

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1781.747	-	31.503
=	1750.244

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2973.914	-	1835	-	99.295
=	1039.619

Krebs Biochemicals & Industries Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Krebs Biochemicals & Industries (BOM:524518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

KREBSBIO:India

Address

Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034

Website

http://www.krebsbiochem.com

Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.

Krebs Biochemicals & Industries (BOM:524518) Headlines

No Headlines